Search Non-invasive Clinical Biomarker Discovery and Development with the Breath Biopsy OMNI Assay A webinar introducing the Breath Biopsy OMNI Assay and the recently released Breath Biopsy Panel In this webinar, Jeff Buckthal, Senior Business Development Manager at Owlstone Medical, presents on the Breath Biopsy® Platform and the latest advancements of the Breath Biopsy OMNI Assay. Our Head of Clinical and Translational Science, Dr. Robert Mohney, introduces a series of case studies, showcasing the applications of breath analysis and the potential for its use in clinical practice. This is a 47 minute on-demand webinar for anyone interested in learning about Breath Biopsy and its capabilities for early detection of disease and precision medicine. The presentation is followed by a Q&A session. If you have a question regarding the webinar or would like to learn more about using Breath Biopsy in your research, please Get In Touch with our Team. Watch the 12-minute webinar introduction: Fill the form below to watch the whole webinar: (If you are unable to see this form please check your browser's Privacy Settings and make sure you are not blocking cookies. If you are still having problems seeing this form, please contact us at breathbiopsy@owlstone.co.uk) Owlstone Medical is developing a breathalyzer for disease for the early detection of cancer, inflammatory and infectious disease. Our mission is to save 100,000 lives and $1.5B in healthcare costs. CONTACTS Cambridge, UK (Visiting): +44 (0)1223 428200 Cambridge, UK: +44 (0)1223 428200 North Carolina, USA: 984-244-7811 Connecticut, USA: +1 203-908-4848 Get in touch with us CONNECT WITH US CONTACT US Twitter LinkedIn Facebook Owlstone Medical's Products and Services are for research use only. Not for use in diagnostic procedures. © Owlstone Medical Ltd 2021 Privacy Policy Cookie Policy Legal Notice and Other Policies Designed & built by Onespacemedia